Webcasts
- Hepatitis C - Already Aging at 25 Years!!!
- Year in Review - Alcoholic Liver Disease
- Changing Landscape of Hepatitis C in India
- Barriers in Hepatitis C Management
- Post Liver Transplant Complications
- Post liver Transplant Complications – Year in Review
- Cirrhosis Management in the ICU: A Gastroenterologist’s Perspective
- Management of Hepatitis B in Special Populations
- Management of Drug-Induced Liver Disease
- Advances in Hepatic Encephalopathy
- Strategies for Sustaining Success in HBV Treatment
Our Publications
- Liver Disease and Pregnancy
- Approach to Hepatitis B in Pregnancy
- HCV Management Series: Management of Treatment-naïve and Treatment-experienced HCV Patients
- HCV: Epidemiology, Screening and Diagnosis
- Muscle Cramps in Liver Cirrhosis
- Antithrombotics in Gastroenterology
- Coagulopathy in Liver Disease
- Managing Treatment Response and Resistance in Hepatitis B
- Rixmin (Rifaximin) Datasheet
- Practice Guidelines for Chronic Hepatitis B
- Strategies for Sustaining Success in HBV Treatment: Webcast Highlights
- Q & A: Strategies for Sustaining Success in HBV Treatment
- Tenofovir Key Abstracts - Liver Meeting 2009
Key Trials
- Efficacy and Safety of Obeticholic Acid Therapy in Primary Biliary Cholangitis
- Tenofovir Alafenamide Fumarate Might be a Feasible Alternative in Chronic HBV Infected Patients Treated with Other Antiviral Drugs
- Long-Term Treatment with Rifaximin Reduces Rate of Hospitalization in Recurrent Hepatic Encephalopathy
- Obeticholic Acid is Effective and Safe in Primary Biliary Cholangitis – A 3-Year Interim Analysis of POISE Trial
- Diagnosis of Minimal Hepatic Encephalopathy in Indian Cirrhotic Patients – Better Tolerability with Rifaximin than Lactulose
- Tinidazole versus Metronidazole in Treatment of Amoebic Liver Abscess
- Efficacy and Safety of Tenofovir Alafenamide in Chronic Hepatitis B Infection
- Long Term Efficacy and Safety of Tenofovir in Chronic Hepatitis B infection
- Cessation of Nucleos(t)ide Analogue Therapy after HBeAg Seroconversion Might Be Associated with High Relapse Rates and Fatal Outcomes
- Maternal Use of Tenofovir: No Additional Benefit in Lowering Perinatal HBV Transmission
- Sofosbuvir - Velpatasvir FDC for HCV Genotypes 1 to 6 Infection – Integrated Analyses of ASTRAL Studies
- Efficacy of Tenofovir Alone in Hepatitis B Patients with Suboptimal Virologic Response to Adefovir
- Tenofovir Benefits Patients with Severe Reactivation of Hepatitis B
- Entecavir Lowers the Incidence of Hepatocellular Carcinoma in HBV Infected Patients
- Long Term Treatment with Tenofovir Might Result in Regression of Cirrhosis in Patients with Chronic Hepatitis B infection
Conference Proceedings
- AASLD 2017: Hepatitis C Updates
- EASL 2017 Series: Hepatitis B
- EASL 2017 Series: Hepatic Encephalopathy
- EASL 2017 Series: Hepatitis C
- AASLD 2015: Hepatology Updates
- AASLD 2015: Hepatitis C Updates
- AASLD 2015: Hepatitis B Updates
- AASLD 2011 Series - Booklet 4: Miscellaneous
- AASLD 2011 Series - Booklet 3: Hepatic Encephalopathy
- AASLD 2011 Series - Booklet 2: Entecavir in Hepatitis B
- AASLD 2011 Series - Booklet 1: Tenofovir in Hepatitis B
- EASL 2011 Series - Booklet 4 : Tenofovir in Hepatitis B
- EASL 2011 Series - Booklet 2 : Encephalopathy and Cirrhosis
- EASL 2011 Series - Booklet 3 : Fatty Liver Disease
- EASL 2011 Series - Booklet 1 : Entecavir in Hepatitis B
Patient Education
Clinical Tools
- Guide to First Line HBV Therapy
- Chronic Hepatitis B Infection: WHO Recommendations for Treatment
- Maddrey’s Discriminant Function for Alcoholic Hepatitis
- King’s College Criteria for Liver Transplantation in ALF (acute liver failure)
- Cockcroft-Gault GFR Calculator (with SI Units)
- Hepatic Encephalopathy Grades/Stages
- Glasgow Alcoholic Hepatitis Score
- MELD Score (Model for End-Stage Liver Disease) (12 and older)
- Child-Pugh Score for Cirrhosis Mortality
- PELD Score (Pediatric End-Stage Liver Disease) (younger than 12)
Guidelines
- ACP & CDC: Hepatitis B Vaccination, Screening, and Linkage to Care (2017)
- ACG Practice Guideline: Evaluation of Abnormal Liver Chemistries (2017)
- EASL Recommendations on Treatment of Hepatitis C- 2016
- APASL: Consensus Guidelines on Invasive and Non-invasive Assessment of Hepatic Fibrosis (2016)
- APASL: Chronic Hepatitis B: Consensus Statement (2016)
- AASLD: Recommendations for Testing, Managing, and Treating Hepatitis C (2014)
- AASLD: Long-Term Management of the Successful Adult Liver Transplant: Practice Guidelines (2012)
- AASLD: Management of Adult Patients with Ascites Due to Cirrhosis: An Update (2012)
- EASL: Chronic Hepatitis B: Clinical Practice Guidelines (2012)
- AASLD: Diagnosis and Management of Autoimmune Hepatitis: Practice Guidelines (2010)
- EASL: Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis: Clinical Practice Guidelines (2010)
- EASL: Management of HFE Hemochromatosis: Clinical Practice Guidelines (2010)
- AASLD: Alcoholic Liver Disease: Practice Guidelines (2010)
- AASLD: The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal HypertensionPractice Guidelines: Update (2009)
- AASLD: Liver Biopsy: Position Paper (2009)
- AASLD: Chronic Hepatitis B: Practice Guidelines (2009)
- AASLD: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis: Practice Guidelines (2007)
Webcasts
Our Publications
Key Trials
- Treating Functional Constipation in Children: PEG 3350 vs. Lactulose
- Once-Daily Dosing of Mesalazine is As Effective and Safe as Twice-Daily Dosing in Ulcerative Colitis
- Long-term Efficacy and Safety of Polyethylene Glycol as Maintenance Treatment for Childhood Functional Constipation
- L Rhamnosus GG Reduced Duration of Diarrhoea In Children with Acute Gastroenteritis: Result of A Meta-Analysis
Patient Education
Clinical Tools
Guidelines
- BSG: Management of Irritable Bowel Syndrome (2021)
- ASGE: Bowel Preparation for Colonoscopy: Consensus Document (2015)
- AGA: Constipation: Medical Position Statement (2014)
- WGO: Acute Diarrhea: Practice Guidelines (2012)
- AGA: Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease: Medical Position Statement (2010)
- ACG: Ulcerative Colitis: Practice Guidelines (2010)
- ACG: Management of Irritable Bowel Syndrome: An Evidence-Based Systematic Review (2009)
- AASLD: Diagnosis and Treatment of Wilson Disease: Practice Guidelines (2008)
- AGA: Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease: Technical Review (2006)
Patient Education
Clinical Tools
Webcasts
Our Publications
Key Trials
- Long-term Treatment with PPIs, Effective and Safe for Treating Eosinophilic Esophagitis in Children
- Esomeprazole Achieves Relief of Nighttime Heartburn and Improves Sleep Quality in GERD
- Short Term Proton Pump Inhibitor Use Can Increase Risk of Hip Fracture in Elderly Alzheimer Patients
- Non-Endoscopic Method for Detection of Barrett’s Esophagus with DNA Methylation Biomarkers
- High or Low Dose Proton Pump Inhibitors, With or Without Diuretics, Do Not Cause Hypomagnesemia
Patient Education
Clinical Tools
Guidelines
- ACG Guideline: Management of Dyspepsia (2017)
- Maastricht V/Florence Consensus: Management of Helicobacter pylori Infection (2016)
- Asia-Pacific Consensus: Management of Gastro-oesophageal Reflux Disease - An Update (2016)
- NICE: Diagnosis and Management of Gastroesophageal Reflux Disease in Children and Young People (2015)
- ACG: Gastroparesis Guideline: Highlights (2013)
- AGA: Barrett's Esophagus: Medical Position Statement (2011)
- NASPGHAN & ESPGHAN: Pediatric Gastroesophageal Reflux: Clinical Practice Guidelines (2009)
- ACG: Prevention of NSAID-Related Ulcer Complications: Guideline (2009)
- AGA: Management of Gastroesophageal Reflux Disease: Medical Position Statement (2008)